Health TrialsbyHealthPanel

Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions

ConditionGingival Recession
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-60
SponsorCairo University

About this trial

treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years old good oral hygiene

Disqualifiers

smokers patients with poor oral hygiene

Trial design

Design model

Parallel

Treatments tested in this trial

  • Connective tissue graft

    Other intervention

    regenerative properties

  • ALB-PRF

    Biological/Vaccine

    regenerative properties

Treatment groups

26 Participants
are divided into 2 treatment groups
Group A: patients with gingival recession control groupActive comparator 1 intervention
Group B: patients with gingival recession interventional groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

mean root coverage

primary outcome measures of mean root coverage in millimeters by UNC15 periodontal probe

Time frame
6 months

Secondary outcomes

1

the percentage of mean root coverage

secondary outcome measures in percentage by UNC15 probe

Time frame
6 months
2

the percentage of complete root coverage

measures in percentage by using UNC periodontal probe

Time frame
6 months
3

recession depth

measures in millimeters by using UNC15 periodontal probe

Time frame
6 months
4

recession width

measures in millimeters by using UNC 15periodontal probe

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov
Apply now